🔎 Trials Near Me

Home › Acute Biphenotypic Leukemia › Utah

Acute Biphenotypic Leukemia clinical trials in Utah

3 studies for Acute Biphenotypic Leukemia are looking for participants at sites in Utah.

Cities in Utah

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Primary Children's Hospital, Salt Lake City
RecruitingPhase 3
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Primary Children's Hospital, Salt Lake City
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.